毒素A型对三神经疼痛的治疗效果:1型与2型三神经疼痛之间是否有任何差异?
Yan Tereshko1,2, Mariarosaria Valente1,2, Enrico Belgrado3
1Clinical Neurology Unit, Udine University Hospital, Piazzale Santa Maria della Misericordia 15, 33100 Udine, Italy.
Toxins
|November 24, 2023
概括
毒素A型有效治疗1型和2型患者的三角神经疼痛 (TN). 这项研究发现,在治疗后,TN类型之间的疼痛减轻或疼痛频率没有显著差异.
科学领域:
- 神经学 神经学
- 疼痛管理 疼痛管理
- 药理学 药理学是指药理学的学科.
背景情况:
- 三神经疼痛 (TN) 是一种使人虚弱的疾病.
- 毒素A型 (BoNT/A) 在TN治疗中表现有前途.
- 需要进一步研究不同TN类型的BoNT/A疗效.
研究的目的:
- 为了评估onabotulinumtoxinA在治疗1型和2型三角神经疼痛中的疗效.
- 为了比较1型和2型TN患者之间的治疗结果.
主要方法:
- 40名TN患者 (18名1型,22名2型) 接受了abotulinumtoxinA.治疗.
- 疼痛评分 (VAS) 和的频率在基线,1个月和3个月被评估.
- 宾夕法尼亚面部疼痛量表 (PFPS) 在基线和1个月后进行了评估.
主要成果:
- 在1个月和3个月后,TN两种类型的疼痛强度和频率显著降低.
- 在1型和2型TN之间没有观察到疼痛减轻或疼痛频率的显著差异.
- 在背景和发性疼痛强度之间发现了强烈的相关性.
结论:
- 胺毒素A是1型和2型三角神经疼痛的有效治疗方法.
- 在这两种TN类型之间,治疗结果是可比的.
- 面部不对称是唯一报告的不良事件.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
684
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
684
Local Anesthetics: Adverse Effects
421
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
421
Local Anesthetics: Differential Sensitivity of Nerve Fibers
840
Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
840
Skeletal Muscle Relaxants: Therapeutic Uses
491
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
491
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
431
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
431
Drugs Acting on Autonomic Ganglia: Blockers
1.0K
Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
1.0K


